Impact of treatment with TransCon PTH on Quality of Life, cognitive function, brain structure, and cerebral capillary bloodflow in patients with hypoparathyroidism
Фаза 4 – наблюдение след одобрението на пазара
Заболявания:
Hypoparathyroidism
Спонсор: Region Midtjylland
Налично на:
БГ
Обобщение
Trial status: Authorised
Correlation between cognitive impairment measured by neuropsychological assessment and capillary transit time heterogeneity, cortical blood volume and hemodynamic parameters., Status of cognitive function in PTH treated compared to conventional treated controls, Difference in groups in size of structures in the brain.
Difference in microvascular hemodynamic between PTH- and conventionally treated patients with chronic HypoPT
Описание
Correlation between cognitive impairment measured by neuropsychological assessment and capillary transit time heterogeneity, cortical blood volume and hemodynamic parameters., Status of cognitive function in PTH treated compared to conventional treated controls, Difference in groups in size of structures in the brain.
Кой може да участва
Age group: 65+ years, 18-64 years
Gender: Female, Male
Target enrollment: 40 participants
Интервенции
Alfacalcidol Stada 1 micrograme capsule moi
Drug
Yorvipath 168 micrograms/0.56 mL solution for injection in pre‑filled pen
БГ
EN